Schedule 13D ownership disclosure
ASTRIA THERAPEUTICS INC
Class A Common Stock, par value $0.001 · CUSIP: 04635X102
Event date: 2026-01-26
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Magnetar Financial LLCReported CIK 0001352851
Shares: 0.00 · Class: 0%
- Magnetar Capital Partners LPReported CIK 0001353085
Shares: 0.00 · Class: 0%
- Supernova Management LLCReported CIK 0001368026
Shares: 0.00 · Class: 0%
- David J. SnydermanReported CIK 0001953511
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-26-007234
- Form type
- SCHEDULE 13D/A
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jan 28, 2026
- Reporting period
- Jan 26, 2026
- Description
- Schedule 13D beneficial ownership